Location Cleveland, Ohio, United States Regions Great Lakes, Midwestern US Gender Male
LinkedIn View on LinkedIn
Stephen Charles leads business development efforts on the pharmaceuticals team at BioEnterprise Corporation, including biopharmaceuticals, biomaterials, and diagnostics. Dr. Charles is a successful entrepreneur with both business and technical skills gained over 35 years in the biotechnology and healthcare (biopharmaceuticals, medical devices, and
diagnostics) sectors.
His most recent role was as cofounder of Kodiak Sciences Inc. (formerly known as Oligasis LLC), a biopharmaceutical company developing first-in-class treatments for retinal diseases, where he fulfilled key operational roles as Chief Technology Officer.
During his career, Charles conceived of and/or played key development roles in multiple successful, technology-rich, long-lived, marketed product platforms: J&J Ortho’s Vitros central laboratory diagnostic system (formally Amersham’s Amerlite system); GE Healthcare’s Biacore biosensor (technology developed at Amersham); CooperVision’s Proclear range of contact lenses (technology developed at Biocompatibles); Medtronic’s Endeavor drug-eluting coronary stent (technology developed at Biocompatibles); and several PEGylated biopharmaceutical products (technology developed at Shearwater/Nektar).
Charles earned his B.Sc., with honors, and Ph.D. degrees in biochemistry from the University of London.
